A detailed history of Virtus ETF Advisers LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 55,075 shares of IRWD stock, worth $194,414. This represents 0.11% of its overall portfolio holdings.

Number of Shares
55,075
Previous 55,075 -0.0%
Holding current value
$194,414
Previous $359,000 37.05%
% of portfolio
0.11%
Previous 0.18%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.58 - $8.61 $121,632 - $187,680
21,798 Added 65.5%
55,075 $359,000
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $39,836 - $73,974
4,788 Added 16.81%
33,277 $289,000
Q4 2023

Feb 15, 2024

BUY
$8.79 - $11.51 $8,359 - $10,946
951 Added 3.45%
28,489 $325,000
Q3 2023

Nov 07, 2023

SELL
$8.25 - $11.35 $29,361 - $40,394
-3,559 Reduced 11.44%
27,538 $265,000
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $63,215 - $72,604
6,259 Added 25.2%
31,097 $330,000
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $4,552 - $5,513
439 Added 1.8%
24,838 $261,000
Q4 2022

Feb 14, 2023

BUY
$9.9 - $12.43 $37,907 - $47,594
3,829 Added 18.61%
24,399 $302,000
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $3,072 - $3,751
303 Added 1.5%
20,570 $213,000
Q2 2022

Aug 12, 2022

SELL
$11.05 - $12.72 $152,434 - $175,472
-13,795 Reduced 40.5%
20,267 $234,000
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $72,034 - $92,530
-6,633 Reduced 16.3%
34,062 $397,000
Q3 2021

Nov 15, 2021

SELL
$11.92 - $13.92 $44,413 - $51,865
-3,726 Reduced 8.39%
40,695 $531,000
Q2 2021

Aug 10, 2021

SELL
$10.16 - $13.11 $70,002 - $90,327
-6,890 Reduced 13.43%
44,421 $572,000
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $12,683 - $16,639
1,403 Added 2.81%
51,311 $574,000
Q4 2020

Feb 12, 2021

SELL
$9.05 - $12.2 $127,043 - $171,263
-14,038 Reduced 21.95%
49,908 $568,000
Q3 2020

Nov 13, 2020

BUY
$8.99 - $10.74 $48,420 - $57,845
5,386 Added 9.2%
63,946 $575,000
Q2 2020

Aug 05, 2020

BUY
$9.14 - $11.97 $114,770 - $150,307
12,557 Added 27.3%
58,560 $604,000
Q1 2020

May 14, 2020

SELL
$8.58 - $14.01 $33,307 - $54,386
-3,882 Reduced 7.78%
46,003 $464,000
Q4 2019

Feb 13, 2020

SELL
$8.22 - $14.0 $139,172 - $237,034
-16,931 Reduced 25.34%
49,885 $664,000
Q3 2019

Nov 12, 2019

SELL
$8.59 - $10.96 $96,585 - $123,234
-11,244 Reduced 14.4%
66,816 $574,000
Q2 2019

Aug 13, 2019

BUY
$9.8 - $12.89 $90,640 - $119,219
9,249 Added 13.44%
78,060 $854,000
Q1 2019

May 14, 2019

BUY
$8.27 - $12.73 $132,229 - $203,539
15,989 Added 30.27%
68,811 $931,000
Q4 2018

Feb 05, 2019

BUY
$7.8 - $16.13 $83,397 - $172,461
10,692 Added 25.38%
52,822 $547,000
Q3 2018

Nov 14, 2018

BUY
$14.31 - $17.65 $40,626 - $50,108
2,839 Added 7.23%
42,130 $778,000
Q2 2018

Aug 10, 2018

SELL
$11.83 - $16.2 $233,323 - $319,512
-19,723 Reduced 33.42%
39,291 $751,000
Q1 2018

May 14, 2018

SELL
$11.13 - $13.63 $38,799 - $47,514
-3,486 Reduced 5.58%
59,014 $911,000
Q4 2017

Feb 14, 2018

BUY
$12.16 - $14.58 $50,512 - $60,565
4,154 Added 7.12%
62,500 $937,000
Q2 2017

Aug 14, 2017

BUY
N/A
58,346
58,346 $1.1 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.